Nat Clin Pract Cardiovasc Med. 2006;3(7):346-347. Since the first widespread clinical application of left ventricular assist devices (LVADs) for patients with end-stage heart failure in the late 1980s ...
Byfield is one of over 100,000 people waiting for a life-saving organ transplant in the country.
IIIF provides researchers rich metadata and media viewing options for comparison of works across cultural heritage collections. Visit the IIIF page to learn more. The HeartMate II Left Ventricular ...
Medicare beneficiaries with heart failure who are Black or female were less likely to receive a left ventricular assist device (LVAD) implantation compared with White and male beneficiaries. Between ...
Mechanical circulatory support systems for the treatment of end-stage heart failure are now available for a wide variety of clinical situations and support times. Extracorporeal membrane oxygenation ...
Ventricular assist devices are mechanical pumps that take over the function of the damaged ventricle in order to re-establish normal hemodynamics and end-organ blood flow. In addition, VADs unload the ...
Despite the general success of left ventricular assist devices (LVADs) used in critically ill heart failure patients, implantation of these devices often leads to increased bleeding and a need for ...
Fineheart SA will soon begin a first-in-human study of Flowmaker, its fully implantable left ventricular assist device, in France, after receiving authorization from the French National Agency for the ...
A multi-institution research effort led by Harvard Medical School, Boston, has looked into the safety and efficacy of excluding aspirin from the treatment of patients with advanced heart failure ...
There is no clearly established strategy for the treatment of a patient with cardiomyopathy and a symptomatic aneurysm of the thoracic aorta. We report the successful use of an approach combining ...
Connex Biomedical Inc. applied for patent protection for a transcardiac access port affixed and retained post-procedure on the cardiac muscle, such as the ventricular myocardium, and an access port ...
LONDON--(BUSINESS WIRE)--The ventricular assist devices market is poised to grow by USD 943.27 million during 2020-2024, progressing at a CAGR of almost 12% during the forecast period. Request free ...